Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
Angiology|January 1, 1996
Power spectral analysis of heart rate in elderly hypertensive subjects with or without silent coronary diseaseG Piccirillo, F L Fimognari, E Santagada, et al.Mbio|February 20, 2014
Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondiiGezahegn Gorfu, Kimberly M Cirelli, Mariane B Melo, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2000
Effect of high-flux dialysis on the anaemia of haemodialysis patientsF Locatelli, S Andrulli, F Pecchini, et al.Journal of the National Cancer Institute|December 10, 2013
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trialAngelo Di Leo, Guy Jerusalem, Lubos Petruzelka, et al.Breast Cancer Research and Treatment|February 5, 2013
Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodologySally Anne Garnett, Miguel Martin, Guy Jerusalem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancerAngelo Di Leo, Guy Jerusalem, Lubos Petruzelka, et al.Archives of Gerontology and Geriatrics|July 26, 2008
Baroreflex sensitivity in the elderly with silent myocardial ischemiaG Piccirillo, F Vetta, S Ronzoni, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 30, 1998
Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cellsI Carrió, P L Pieri, J Narula, et al.Journal of Neurology|July 22, 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationD Ferraro, P Iaffaldano, T Guerra, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2015
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trialG Bianchini, L Pusztai, T Pienkowski, et al.Pageof 13